FDA Label for Cyclease Pms

View Indications, Usage & Precautions

Cyclease Pms Product Label

The following document was submitted to the FDA by the labeler of this product Laboratoires Boiron. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.

Otc - Active Ingredient



Folliculinum 15C, Natrum muriaticum 12C, Sepia 12C


Indications & Usage



Temporary relieves premenstrual symptoms such as: discomfort, aches, bloating, irritability.


Otc - Do Not Use



Do not use if glued carton en flaps are open or if the blister seal is broken


Dosage & Administration



Adults and children 12 years of age and older: Dissolve 2 tablets in the mouth morning and evening until symptoms are relieved.
Children under 12 years of age: Not recommended


Inactive Ingredient



Croscarmellose sodium, lactose, magnesium stearate


How Supplied



60 tablets


Otc - Purpose



Folliculinum 15C ...Relieves discomfort and aches associated with PMS
Natrum muriaticum 12C ...Relieves water retention and irritability
Sepia 12C...Relieves bloating and lower back pain.


Storage And Handling



Store at 68-77 o F


Otc - Questions



Questions, Comments
www.boironusa.com
[email protected]
1-800-BOIRON-1
(1-800-264-7661)
Boiron Information Center
6 campus boulevard
Newtown Square, PA
19073-3267


Otc - Ask Doctor





Otc - Stop Use



Stop use and ask a doctor if symptoms persist for more than 7 days or worsen.


Otc - Keep Out Of Reach Of Children



Keep out of reach of children


Otc - Pregnancy Or Breast Feeding



If pregnant or breast-feeding, ask a health professional before use.


Otc - When Using





Drug Interactions



Safe - no side effects - no drug interactions - works naturally with your body


Warnings



Enter section text here


* Please review the disclaimer below.